Is Carter's Wholesale Segment Weakness Dragging Overall Growth?
CRI's growth is held back by U.S. Wholesale declines tied to Simple Joys, offsetting gains in Retail and International.
Why Is Carter's (CRI) Down 1% Since Last Earnings Report?
Carter's (CRI) reported earnings 30 days ago. What's next for the stock?
Carter's (CRI) Q3 Earnings Lag Estimates
Carter's (CRI) came out with quarterly earnings of $0.74 per share, missing the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $1.64 per share a year ago.
Carter's: Oversold With Potential Catalysts
Carter's shares have halved amid weak consumer spending, tariff headwinds, and demographic challenges limiting baby apparel growth. Margins are under severe pressure from tariffs and limited pricing power, with structural costs unlikely to be fully offset by price hikes. The recent poison pill adoption signals corporate intrigue after Roseman Wagner Wealth Management acquired a 17% stake, raising potential for activist involvement.
1 Company Who Recently Cut Its Dividend By 69%, And 1 Who Could Potentially Cut In The Near Future
Dividend cuts are rising as companies face persistent high interest rates, inflation, and changing consumer behavior, impacting even long-standing dividend payers. Carter's slashed its dividend by 69% due to deteriorating financials, tariff uncertainty, and a challenging macro environment, despite a strong balance sheet. Pepsi, a Dividend King, is experiencing cash flow issues; while recent acquisitions are promising, a dividend cut is possible if headwinds persist or a recession hits.
Carter's Q2 Earnings Miss Estimates, Stock Dips After Tariff Concerns
CRI's shares tumble after Q2 earnings miss as tariff concerns weigh on outlook despite stronger sales trends.
Carter's Q2 Results Were Not Good, And Tariffs' Impact Is Still Incoming
Carter's posted positive comp sales and unit growth, signaling market share gains despite a declining US baby population. Profitability sharply deteriorated, with adjusted operating income down 75% and GAAP profits nearly breakeven due to price cuts, off-price sales, and rising SG&A. Upcoming tariffs pose major cost headwinds, and planned price increases may not be fully absorbed by consumers, risking further volume and profit declines.
Carter's: Going Against The Market's Narrative As Sales Turn
Carter's, Inc. has reported consistent sales declines over the past few years. Competition from Temu and Shein has pressured Carter's competitive positioning. Tariff changes have deteriorated Temu's and Shein's business model in the U.S. Carter's Q2 report underlines the change's benefit, as U.S. sales growth suddenly turned positive. The Q2 report did come with negatives as profitability faltered. Tariffs add pressure to upcoming quarters, although Carter's should manage to increasingly mitigate tariffs.
Carter's, Inc. (CRI) Q2 2025 Earnings Conference Call Transcript
Carter's, Inc. (NYSE:CRI ) Q2 2025 Earnings Call July 25, 2025 8:30 AM ET Executives Douglas C. Palladini – CEO, President & Director Richard F.
Carter's (CRI) Misses Q2 Earnings Estimates
Carter's (CRI) came out with quarterly earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.76 per share a year ago.
What Should Investors Expect From Carter's Ahead of Q2 Earnings?
CRI's Q2 revenues are expected to have climbed on baby and global gains, but pricing and costs are likely to have weighed on the bottom line.
3 Value Stocks Going for Bargain Basement Prices
The U.S. stock market may be at a fresh all-time high, with the S&P 500 closing in on 6,300, but, as they say, the stock market is a market of stocks.
